Hormonal influences in multiple sclerosis

Current Topics in Microbiology and Immunology

Volumn 318, Issue , 2008, Pages 267-311

  Shuster, E A ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; CONTRACEPTIVE AGENT; CYTOKINE; DEXAMETHASONE; ESTRIOL; ESTROGEN; ETHINYLESTRADIOL; FLUOCORTOLONE; GHRELIN; GLUCOCORTICOID; IMMUNOGLOBULIN; INTERFERON BETA SERINE; INTERLEUKIN 1; INTERLEUKIN 6; LEPTIN; MESTRANOL PLUS NORETYNODREL; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MITOXANTRONE; MOCLOBEMIDE; MYELIN; PRASTERONE; PREDNISOLONE; PROGESTERONE; PROLACTIN; RO 632023; TESTOSTERONE; THYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; TX 527; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D; HORMONE; SEX HORMONE;

ABSENCE OF SIDE EFFECTS; ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE THYROIDITIS; BRAIN NERVE CELL; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG MEGADOSE; GLIA CELL; HORMONAL CONTRACEPTION; HORMONE ACTION; HORMONE RESPONSE; HUMAN; HYPOTHALAMUS DISEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHYROIDISM; IMMUNOMODULATION; INFLAMMATION; LOW DRUG DOSE; MENSTRUAL CYCLE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; OPTIC NEURITIS; PLASMAPHERESIS; PREGNANCY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SUNLIGHT; THROMBOSIS; THYROID DISEASE; ANIMAL; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GHRELIN; GONADAL STEROID HORMONES; HORMONES; HUMANS; LEPTIN; MALE; MICE; MULTIPLE SCLEROSIS; PREGNANCY; THYROID HORMONES; VITAMIN D;

EID: 39549103852     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-73677-6_11     Document Type: Review

References (237)

1. Abramsky O, Lubetzki-Korn I, Evron S, Brenner T (1984) Suppressive effect of pregnancy on MS and EAE. Prog Clin Biol Res 146:399-406
2. Achiron A, Barak Y, Miron S, Izhak Y, Faibel M, Edelstein S (2003) Alfacalcidol treatment in multiple sclerosis. Clin Neuropharmacol 26:53
3. Achiron A, Kishner I, Dolev M, Stern Y, Dulitzky M, Schiff E, Achiron R (2004) Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 251:1133-1137
4. Achiron A, Rotstein Z, Noy S, Mashiach S, Dulitzky M, Achiron R (1996) Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis: A pilot study. J Neurol 243:25-28
5. Al-Shammri S, Rawoot P, Azizieh F, AbuQoora A, Hanna M, Saminathan TR, Raghupathy R (2004) Th1/th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis. J Neurol Sci 222:21-27
6. Allan CA, McLachlan RI (2006) Androgen deficiency disorders. In: DeGroot LJ, Jameson JL (eds) Endocrinology. Elsevier Saunders, Philadelphia, pp 3159-3192
7. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 291:1701-1712
8. Angelucci F, Mirabella M, Caggiula M, Frisullo G, Patanella K, Sancricca C, Nociti V, Tonali PA, Batocchi AP (2005) Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis. Peptides 26:2289-2293
9. Annunziata P, Lore F, Venturini E, Morana P, Guarino E, Borghi S, Guazzi GC (1999) Early synthesis and correlation of serum anti-thyroid antibodies with clinical parameters in multiple sclerosis. J Neurol Sci 168:32-36
10. Aoki N (1999) Klinefelter's syndrome, autoimmunity, and associated endocrinopathies. Intern Med 38:838-839
11. Arnason BG, Richman DP (1969) Effect of oral contraceptives on experimental demyelinating disease. Arch Neurol 21:103-108
12. Azar ST, Yamout B (1999) Prolactin secretion is increased in patients with multiple sclerosis. Endocr Res 25:207-214
13. Baas D, Bourbeau D, Sarlieve LL, Ittel ME, Dussault JH, Puymirat J (1997) Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone. Glia 19:324-332
14. Bansil S, Lee HJ, Jindal S, Holtz CR, Cook SD (1999) Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis. Acta Neurol Scand 99:91-94
15. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O'Garra A (2002) In vitro generation of interleukin 10-producing regulatory CD4(+) t cells is induced by immunosuppressive drugs and inhibited by t helper type 1 (th1)- and th2-inducing cytokines. J Exp Med 195:603-616
16. Batuman OA, Ferrero A, Cupp C, Jimenez SA, Khalili K (1995) Differential regulation of transforming growth factor beta-1 gene expression by glucocorticoids in human T and glial cells. J Immunol 155:4397-4405
17. Bebo BF Jr, Dveksler GS (2005) Evidence that pregnancy specific glycoproteins regulate T-cell function and inflammatory autoimmune disease during pregnancy. Curr Drug Targets Inflamm Allergy 4:231-237
18. Bebo BF Jr, Fyfe-Johnson A, Adlard K, Beam AG, Vandenbark AA, Offner H (2001) Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 166:2080-2089
19. Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR et al (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 326:581-588
20. Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, Brown CH (1993) The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med 329:1764-1769
21. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F (1997) Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol Pharmacol 51:535-541
22. Berilgen MS, Bulut S, Ustundag B, Tekatas A, Ayar A (2005) Patients with multiple sclerosis have higher levels of serum ghrelin. Neuro Endocrinol Lett 26:819-822
23. Bernton EW, Meltzer MS, Holaday JW (1988) Suppression of macrophage activation and t-lymphocyte function in hypoprolactinemic mice. Science 239:401-404
24. Besedovsky H, del Rey A, Sorkin E, Dinarello CA (1986) Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233:652-654
25. Bissay V, De Klippel N, Herroelen L, Schmedding E, Buisseret T, Ebinger G, De Keyser J (1994) Bromocriptine therapy in multiple sclerosis: An open label pilot study. Clin Neuropharmacol 17:473-476
26. Bolton C, O'Neill JK, Allen SJ, Baker D (1997) Regulation of chronic relapsing experimental allergic encephalomyelitis by endogenous and exogenous glucocorticoids. Int Arch Allergy Immunol 114:74-80
27. Bouillon R (2006) Vitamin D: from photosynthesis, metabolism, and action to clinical applications. In: DeGroot LJ, Jameson JL (eds) Endocrinology. Elsevier Saunders, Philadelphia, pp 1435-1463
28. Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11:411-423
29. Brinar VV, Petelin Z, Brinar M, Djakovic V, Zadro I, Vranjes D (2006) CNS demyelination in autoimmune diseases. Clin Neurol Neurosurg 108:318-826
30. Brunner R, Schaefer D, Hess K, Parzer P, Resch F, Schwab S (2005) Effect of corticosteroids on short-term and long-term memory. Neurology 64:335-337
31. Cantorna MT, Hayes CE, DeLuca HF (1996) 1,25-dihydroxyvitamin d3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 93:7861-7864
32. Carella C, Mazziotti G, Morisco F, Manganella G, Rotondi M, Tuccillo C, Sorvillo F, Caporaso N, Amato G (2001) Long-term outcome of interferon-alpha- induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J Clin Endocrinol Metab 86:1925-1929
33. Carroll WM, Jennings AR (1994) Early recruitment of oligodendrocyte precursors in CNS demyelination. Brain 117:563-578
34. Caruso A, Di Giorgi Gerevini V, Castiglione M, Marinelli F, Tomassini V, Pozzilli C, Caricasole A, Bruno V, Caciagli F, Moretti A, Nicoletti F, Melchiorri D (2004) Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. J Neurochem 88:1179-1185
35. Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-162
36. Chrousos GP, Elenkov IJ (2006) Interactions of the endocrine and immune systems In: DeGroot LJ, Jameson JL (eds) Endocrinology. Elsevier Saunders, Philadelphia, pp 779-818
37. Chrousos GP, Torpy DJ, Gold PW (1998) Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 129:229-240
38. Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans J, Seaman S, Miller DH, Hale G, Waldmann H, Compston DA (2006) The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J Neurol 253:98-108
39. Coles AJ, Wing M, Smith S, Coraddu F, Greer S, Taylor C, Weetman A, Hale G, Chatterjee VK, Waldmann H, Compston A (1999) Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 354:1691-1695
40. Compston DAS, Margolin DH, Haas J, Magner J, Gonzales G, Valente W, Coles A (2006) Two year interim analysis of thyroid abnormalities in a trial of alemtuzumab vs high-dose interferon-beta-1a, for treatment of relapsing-remitting multiple sclerosis. 22nd Congress of the European Committee for the Treatment and Research
41. Confavreux C, Compston A (1998) The natural history of MS. In: McAlpinee D, Compston A, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H (eds)Mcalpine's multiple sclerosis. Churchill Livingstone, Edinburgh, pp 183-272
42. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339:285-291
43. Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: An amnesic process. Brain 126:770-782
44. Coppack SW (2001) Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60:349-356
45. Czock D, Keller F, Rasche FM, Haussler U (2005) Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44:61-98
46. D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, Panina-Bordignon P (1998) Inhibition of il-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101:252-262
47. Dalal M, Kim S, Voskuhl RR (1997) Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J Immunol 159:3-6
48. Damek DM, Shuster EA (1997) Pregnancy and multiple sclerosis. Mayo Clin Proc 72:977-989
49. David PS, Boatwright EA, Tozer BS, Verma DP, Blair JE, Mayer AP, Files JA (2006) Hormonal contraception update. Mayo Clin Proc 81:949-954; quiz 955
50. De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A (2005) Prolactin and autoimmunity. Pituitary 8:25-30
51. De Rosa V, Procaccini C, La Cava A, Chieffi P, Nicoletti GF, Fontana S, Zappacosta S, Matarese G (2006) Leptin neutralization interferes with pathogenic t cell autoreactivity in autoimmune encephalomyelitis. J Clin Invest 116:447-455
52. de Seze J, Chapelotte M, Delalande S, Ferriby D, Stojkovic T, Vermersch P (2004) Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler 10:596-597
53. del Rey A, Klusman I, Besedovsky HO (1998) Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: Involvement of IL-1. Am J Physiol 275:R1146-R1151
54. Demerens C, Stankoff B, Zalc B, Lubetzki C (1999) Eliprodil stimulates cns myelination: New prospects for multiple sclerosis? Neurology 52:346-350
55. DeRijk RH, Eskandari F, Sternberg EM (2004) Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production. J Neuroimmunol 151:180-188
56. Diem R, Hobom M, Maier K, Weissert R, Storch MK, Meyer R, Bahr M (2003) Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway. J Neurosci 23:6993-7000
57. Dijkstra CD, van der Voort ER, De Groot CJ, Huitinga I, Uitdehaag BM, Polman CH, Berkenbosch F (1994) Therapeutic effect of the d2-dopamine agonist bromocriptine on acute and relapsing experimental allergic encephalomyelitis. Psychoneuroendocrinology 19:135-142
58. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD (2004) Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114:57-66
59. Dixit VD, Taub DD (2005) Ghrelin and immunity: A young player in an old field. Exp Gerontol 40:900-910
60. Draca S, Levic Z (1996) The possible role of prolactin in the immunopathogenesis of multiple sclerosis. Med Hypotheses 47:89-92
61. Drew PD, Storer PD, Xu J, Chavis JA (2005) Hormone regulation of microglial cell activation: relevance to multiple sclerosis. Brain Res Brain Res Rev 48:322-327
62. Du C, Khalil MW, Sriram S (2001) Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice. J Immunol 167:7094-7101
63. Durelli L, Ferrero B, Oggero A, Verdun E, Bongioanni MR, Gentile E, Isoardo GL, Ricci A, Rota E, Bergamasco B, Durazzo M, Saracco G, Biava MA, Brossa PC, Giorda L, Pagni R, Aimo G (1999) Autoimmune events during interferon beta-1b treatment for multiple sclerosis. J Neurol Sci 162:74-83
64. Durelli L, Ferrero B, Oggero A, Verdun E, Ghezzi A, Montanari E, Zaffaroni M (2001) Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study. J Clin Endocrinol Metab 86:3525-3532
65. Durelli L, Oggero A, Verdun E, Isoardo GL, Barbero P, Bergamasco B, Brossa PC, Ghigo E, Maccario M, Faggiano F (2001) Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study. J Neurol Sci 193:17-22
66. El-Etr M, Vukusic S, Gignoux L, Durand-Dubief F, Achiti I, Baulieu EE, Confavreux C (2005) Steroid hormones in multiple sclerosis. J Neurol Sci 233:49-54
67. Elenkov IJ, Wilder RL, Bakalov VK, Link AA, Dimitrov MA, Fisher S, Crane M, Kanik KS, Chrousos GP (2001) Il-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 86:4933-4938
68. Elliott GA, Gibbons AJ, Greig ME (1973) A comparison of the effects of melengestrol acetate with a combination of hydrocortisone acetate and medroxyprogesterone acetate and with other steroids in the treatment of experimental alleric encephalomyelitis in Wistar rats. Acta Neuropathol (Berl) 23:95-104
69. Embry AF, Snowdon LR, Vieth R (2000) Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 48:271-272
70. Erkut ZA, Hofman MA, Ravid R, Swaab DF (1995) Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis. J Neuroimmunol 62:27-33
71. Fassbender K, Schmidt R, Mossner R, Kischka U, Kuhnen J, Schwartz A, Hennerici M (1998) Mood disorders and dysfunction of the hypothalamic-pituitary- adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol 55:66-72
72. Fernandez M, Giuliani A, Pirondi S, D'Intino G, Giardino L, Aloe L, Levi-Montalcini R, Calza L (2004) Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc Natl Acad Sci U S A 101:16363-16368
73. Ferrero S, Esposito F, Pretta S, Ragni N (2006) Fetal risks related to the treatment of multiple sclerosis during pregnancy and breastfeeding. Expert Rev Neurother 6:1823-1831
74. Fleming JO, Hummel AL, Beinlich BR, Borowski BJ, Peebles T, Colburn M, Cook TD, Wendt GJ, DeLuca HF (2000) Vitamin d treatment of relapsing-remitting multiple sclerosis (RRMS): A MRI-based pilot study (abstract p05.011). Neurology 54:A338
75. Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395:763-770
76. Garcia-Ovejero D, Azcoitia I, Doncarlos LL, Melcangi RC, Garcia-Segura LM (2005) Glianeuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res Brain Res Rev 48:273-286
77. Garcia-Segura LM, Cardona-Gomez P, Naftolin F, Chowen JA (1998) Estradiol upregulates Bcl-2 expression in adult brain neurons. Neuroreport 9:593-597
78. Garcion E, Sindji L, Nataf S, Brachet P, Darcy F, Montero-Menei CN (2003) Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system. Acta Neuropathol (Berl) 105:438-448
79. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13:100-105
80. Gayo A, Mozo L, Suarez A, Tunon A, Lahoz C, Gutierrez C (1998) Glucocorticoids increase il-10 expression in multiple sclerosis patients with acute relapse. J Neuroimmunol 85:122-130
81. Ghisletti S, Meda C, Maggi A, Vegeto E (2005) 17beta-estradiol inhibits inflammatory gene expression by controlling Nf-kappaB intracellular localization. Mol Cell Biol 25:2957-2968
82. Gilmore W, Arias M, Stroud N, Stek A, McCarthy KA, Correale J (2004) Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients. J Neurol Sci 224:69-76
83. Gogas H, Ioannovich J, Dafni U, Stavropoulou-Giokas C, Frangia K, Tsoutsos D, Panagiotou P, Polyzos A, Papadopoulos O, Stratigos A, Markopoulos C, Bafaloukos D, Pectasides D, Fountzilas G, Kirkwood JM (2006) Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med 354:709-718
84. Gold SM (2006) Neurotrophic factor production by immune cells during testosterone treatment in MS (poster). ACTRIMS
85. Gold SM, Raji A, Huitinga I, Wiedemann K, Schulz KH, Heesen C (2005) Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis. J Neuroimmunol 165:186-191
86. Goldberg P, Fleming MC, Picard EH (1986) Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 21:193-200
87. Gonzalez Deniselle MC, Lopez-Costa JJ, Saavedra JP, Pietranera L, Gonzalez SL, Garay L, Guennoun R, Schumacher M, De Nicola AF (2002) Progesterone neuroprotection in the wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol Dis 11:457-468
88. Goodman Y, Bruce AJ, Cheng B, Mattson MP (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 66:1836-1844
89. Grasser A, Moller A, Backmund H, Yassouridis A, Holsboer F (1996) Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Exp Clin Endocrinol Diabetes 104:31-37
90. Gregg C, Shikar V, Larsen P, Mak G, Chojnacki A, Yong VW, Weiss S (2007) White matter plasticity and enhanced remyelination in the maternal cns. J Neurosci 27:1812-1823
91. Greig ME, Gibbons AJ, Elliott GA (1970) A comparison of the effects of melengestrol acetate and hydrocortisone acetate on experimental allergic encephalomyelitis in rats. J Pharmacol Exp Ther 173:85-93
92. Haas J (2000) High dose IVIG in the postpartum period for prevention of exacerbations in MS. Mult Scler 6 [Suppl 2]:S18-S20; discussion S33
93. Hammond J, Le Q, Goodyer C, Gelfand M, Trifiro M, LeBlanc A (2001) Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J Neurochem 77:1319-1326
94. Harirchian MH, Sahraian MA, Shirani A (2006) Serum prolactin level in patients with multiple sclerosis: a case-control study. Med Sci Monit 12:CR177-CR180
95. Hawkins SA, McDonnell GV (1999) Benign multiple sclerosis? Clinical course, long-term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 67:148-152
96. Heesen C, Gbadamosi J, Schoser BG, Pohlau D (2001) Autoimmune hyperthyroidism in multiple sclerosis under treatment with glatiramer acetate - a case report. Eur J Neurol 8:199
97. Heesen C, Gold SM, Bruhn M, Monch A, Schulz KH (2002) Prolactin stimulation in multiple sclerosis - an indicator of disease subtypes and activity? Endocr Res 28:9-18
98. Heesen C, Schulz H, Schmidt M, Gold S, Tessmer W, Schulz KH (2002) Endocrine and cytokine responses to acute psychological stress in multiple sclerosis. Brain Behav Immun 16:282-287
99. Hench PS, Kendall EC, Slocumb CH, et al (1949) The effect of a hormones of the adrenal cortex (17 hydroxy-11-dehydroxcorticosterone: compound e) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Mayo Clin Proc 24:181-197
100. Hernan MA, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A (2000) Oral contraceptives and the incidence of multiple sclerosis. Neurology 55:848-854
101. Holmqvist P, Wallberg M, Hammar M, Landtblom AM, Brynhildsen J (2006) Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas 54:149-153
102. Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, Nishihara M, Takahashi M, Iwakura Y (1998) Production of mice deficient in genes for interleukin (il)-1alpha, il-1beta, il-1alpha/ beta, and il-1 receptor antagonist shows that il-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 187:1463-1475
103. Huitinga I, De Groot CJ, Van der Valk P, Kamphorst W, Tilders FJ, Swaab DF (2001) Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol 60:1208-1218
104. Huitinga I, Erkut ZA, van Beurden D, Swaab DF (2003) The hypothalamo-pituitary-adrenal axis in multiple sclerosis. Ann N Y Acad Sci 992:118-128
105. Huitinga I, Erkut ZA, van Beurden D, Swaab DF (2004) Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann Neurol 55:37-45
106. Ibanez C, Shields SA, El-Etr M, Leonelli E, Magnaghi V, Li WW, Sim FJ, Baulieu EE, Melcangi RC, Schumacher M, Franklin RJ (2003) Steroids and the reversal of age-associated changes in myelination and remyelination. Prog Neurobiol 71:49-56
107. Institute of Medicine (U.S.). Standing Committee on the Scientific Evaluation of Dietary Reference Intakes (1997) Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academies Press, Washington DC, p xv
108. Ioppoli C, Meucci G, Mariotti S, Martino E, Lippi A, Gironelli L, Pinchera A, Muratorio A (1990) Circulating thyroid and gastric parietal cell autoantibodies in patients with multiple sclerosis. Ital J Neurol Sci 11:31-36
109. Ito A, Bebo BF Jr, Matejuk A, Zamora A, Silverman M, Fyfe-Johnson A, Offner H (2001) Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol 167:542-552
110. Jansson L, Olsson T, Holmdahl R (1994) Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol 53:203-207
111. Jiang N, Chopp M, Stein D, Feit H (1996) Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res 735:101-107
112. Jones SA, Jolson DM, Cuta KK, Mariash CN, Anderson GW (2003) Triiodothyronine is a survival factor for developing oligodendrocytes. Mol Cell Endocrinol 199:49-60
113. Kalman B, Olsson O, Link H, Kam-Hansen S (1989) Estradiol potentiates poke-weed mitogen-induced b cell stimulation in multiple sclerosis and healthy subjects. Acta Neurol Scand 79:340-346
114. Kalueff AV, Tuohimaa P (2007) Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care 10:12-19
115. Kantarci OH, Barcellos LF, Atkinson EJ, Ramsay PP, Lincoln R, Achenbach SJ, De Andrade M, Hauser SL, Weinshenker BG (2006) Men transmit MS more often to their children vs women: the Carter effect. Neurology 67:305-310
116. Kappas A, Jones HE, Roitt IM (1963) Effects of steroid sex hormones on immunological phenomena. Nature 198:902
117. Kappas A, Palmer RH (1963) Selected aspects of steroid pharmacology. Pharmacol Rev 15:123-167
118. Karssen AM, Meijer OC, van der Sandt IC, De Boer AG, De Lange EC, De Kloet ER (2002) The role of the efflux transporter p-glycoprotein in brain penetration of prednisolone. J Endocrinol 175:251-260
119. Keith AB (1978) Effect of pregnancy on experimental allergic encephalomyelitis in guinea pigs and rats. J Neurol Sci 38:317-326
120. Kim S, Voskuhl RR (1999) Decreased IL-12 production underlies the decreased ability of male lymph node cells to induce experimental autoimmune encephalomyelitis. J Immunol 162:5561-5568
121. Kira J, Harada M, Yamaguchi Y, Shida N, Goto I (1991) Hyperprolactinemia in multiple sclerosis. J Neurol Sci 102:61-66
122. Kirk AD, Hale DA, Swanson SJ, Mannon RB (2006) Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab. Am J Transplant 6:1084-1085
123. Koo GC, Huang C, Camacho R, Trainor C, Blake JT, Sirotina-Meisher A, Schleim KD, Wu TJ, Cheng K, Nargund R, McKissick G (2001) Immune enhancing effect of a growth hormone secretagogue. J Immunol 166:4195-41201
124. Koon H, Atkins M (2006) Autoimmunity and immunotherapy for cancer. N Engl J Med 354:758-760
125. Korn-Lubetzki I, Kahana E, Cooper G, Abramsky O (1984) Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol 16:229-231
126. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870
127. Kumpfel T, Then Bergh F, Friess E, Uhr M, Yassouridis A, Trenkwalder C, Holsboer F (1999) Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis. Neuroendocrinology 70:431-438
128. Lassmann H, Wekerle H (1998) The pathology of multiple sclerosis In: McAlpine D, Compston A, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H (eds) Mcalpine's multiple sclerosis. Churchill Livingstone, Edinburgh, pp 557-599
129. Lemire JM, Archer DC, Beck L, Spiegelberg HL (1995) Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of th1 functions. J Nutr 125: 1704S-1708S
130. Leussink VI, Jung S, Merschdorf U, Toyka KV, Gold R (2001) High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes. Arch Neurol 58:91-97
131. Levine S, Sowinski R, Steinetz B (1980) Effects of experimental allergic encephalomyelitis on thymus and adrenal: relation to remission and relapse. Proc Soc Exp Biol Med 165:218-224
132. Li DK, Zhao GJ, Paty DW (2001) Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results. Neurology 56:1505-1513
133. Limberg CC (1948) Demographic distribution of multiple sclerosis and its estimated prevalence in the United States In: Association for Research in Nervous and Mental Disease (ed) Multiple sclerosis and the demyelinating diseases. Conference of the Association for Research in Nervous and Mental Disease, December 10 and 11, 1948, New York. Williams & Wilkins, Baltimore, pp 15-24
134. Limone P, Ferrero B, Calvelli P, Del Rizzo P, Rota E, Berardi C, Barberis AM, Isaia GC, Durelli L (2002) Hypothalamic-pituitary-adrenal axis function and cytokine production in multiple sclerosis with or without interferon-beta treatment. Acta Neurol Scand 105:372-377
135. Lindzey J, Korach KS (2006) Environmental agents and the reproductive system In: DeGroot LJ, Jameson JL (eds) Endocrinology. Elsevier Saunders, Philadelphia, pp 2759-2778
136. Linssen WH, Notermans NC, Hommes OR, Rolland R (1987) Amenorrhea after immunosuppressive treatment of multiple sclerosis. Acta Neurol Scand 76:204-209
137. Liva SM, Voskuhl RR (2001) Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol 167:2060-2067
138. Lopez C, Comabella M, Tintore M, Sastre-Garriga J, Montalban X (2006) Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients. Mult Scler 12:421-427
139. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394:897-901
140. Lowe SA (2001) Drugs in pregnancy. Anticonvulsants and drugs for neurological disease. Best Pract Res Clin Obstet Gynaecol 15:863-876
141. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT (2003) Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 134:128-132
142. Martinelli V, Gironi M, Rodegher M, Martino G, Comi G (1998) Occurrence of thyroid autoimmunity in relapsing remitting multiple sclerosis patients undergoing interferon-beta treatment. Ital J Neurol Sci 19:65-67
143. Mason D, MacPhee I, Antoni F (1990) The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 70:1-5
144. Matarese G, Carrieri PB, La Cava A, Perna F, Sanna V, De Rosa V, Aufiero D, Fontana S, Zappacosta S (2005) Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory t cells. Proc Natl Acad Sci U S A 102:5150-1515
145. Matarese G, Di Giacomo A, Sanna V, Lord GM, Howard JK, Di Tuoro A, Bloom SR, Lechler RI, Zappacosta S, Fontana S (2001) Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 166:5909-5916
146. Mattner F, Smiroldo S, Galbiati F, Muller M, Di Lucia P, Poliani PL, Martino G, Panina-Bordignon P, Adorini L (2000) Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur J Immunol 30:498-508
147. Mattson D, Petrie M, Srivastava DK, McDermott M (1995) Multiple sclerosis. Sexual dysfunction and its response to medications. Arch Neurol 52:862-868
148. Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, Gold PW (1994) Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol Metab 79:848-853
149. Monzani F, Caraccio N, Casolaro A, Lombardo F, Moscato G, Murri L, Ferrannini E, Meucci G (2000) Long-term interferon beta-1b therapy for MS: is routine thyroid assessment always useful? Neurology 55:549-552
150. Morales LB, Loo KK, Liu HB, Peterson C, Tiwari-Woodruff S, Voskuhl RR (2006) Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J Neurosci 26:6823-6833
151. Munck A, Naray-Fejes-Toth A (2006) Glucocorticoid physiology In: DeGroot LJ, Jameson JL (eds) Endocrinology. Elsevier Saunders, Philadelphia, pp 2287-2307
152. Munger KL, Zhang SM, O'Reilly E, Hernan MA, Olek MJ, Willett WC, Ascherio A (2004) Vitamin d intake and incidence of multiple sclerosis. Neurology 62:60-65
153. Muthian G, Raikwar HP, Rajasingh J, Bright JJ (2006) 1,25 dihydroxyvitamin-d3 modulates JAK-stat pathway in il-12/ifngamma axis leading to Th1 response in experimental allergic encephalomyelitis. J Neurosci Res 83:1299-1309
154. Nagy E, Berczi I, Wren GE, Asa SL, Kovacs K (1983) Immunomodulation by bromocriptine. Immunopharmacology 6:231-243
155. Nataf S, Garcion E, Darcy F, Chabannes D, Muller JY, Brachet P (1996) 1,25 dihydroxyvitamin d3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis. J Neuropathol Exp Neurol 55:904-914
156. Niederwieser G, Buchinger W, Bonelli RM, Berghold A, Reisecker F, Koltringer P, Archelos JJ (2003) Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis. J Neurol 250:672-675
157. NMMS Society (2006) A phase 2 study of estriol therapy combined with glatiramer. Research/Clinical Update, Nov 10
158. Noseworthy J, Confavreaux C, Compston A (1998) Treatment of the acute relapse. In: McAlpine D, compston A, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H (eds) Mcalpine's multiple sclerosis.Churchill Livingstone, Edinburgh , pp 683-699
159. Obendorf M, Patchev VK (2004) Interactions of sex steroids with mechanisms of inflammation. Curr Drug Targets Inflamm Allergy 3:425-433
160. Obradovic D, Gronemeyer H, Lutz B, Rein T (2006) Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem 96:500-509
161. Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, Ebers GC (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 5:932-936
162. Ostensen M, Villiger PM (2002) Immunology of pregnancy: pregnancy as a remission inducing agent in rheumatoid arthritis. Transpl Immunol 9:155-160
163. Palaszynski KM, Loo KK, Ashouri JF, Liu HB, Voskuhl RR (2004) Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol 146:144-152
164. Palaszynski KM, Smith DL, Kamrava S, Burgoyne PS, Arnold AP, Voskuhl RR
165. Parry S, Strauss JF. Placental hormones. In: DeGroot LJ, Jameson JL (eds) Endocrinology. Elsevier Saunders, Philadelphia, pp 3353-3368
166. Patwardhan AJ, Eliez S, Bender B, Linden MG, Reiss AL (2000) Brain morphology in Klinefelter syndrome: Extra X chromosome and testosterone supplementation. Neurology 54:2218-2223
167. Penhale WJ, Farmer A, Irvine WJ (1975) Thyroiditis in t cell-depleted rats. Influence of strain, radiation dose, adjuvants and antilymphocyte serum. Clin Exp Immunol 21:362-375
168. Perretti M, Ahluwalia A (2000) The microcirculation and inflammation: site of action for glucocorticoids. Microcirculation 7:147-161
169. Petanceska SS, Nagy V, Frail D, Gandy S (2000) Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Neurology 54:2212-2217
170. Petek-Balci B, Yayla V, Ozer F (2005) Multiple sclerosis and hashimoto thyroiditis: Two cases. Neurologist 11:301-4
171. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63:964-968
172. Poser S, Raun NE, Wikstrom J, Poser W (1979) Pregnancy, oral contraceptives and multiple sclerosis. Acta Neurol Scand 59:108-118
173. Pozzi S, Benedusi V, Maggi A, Vegeto E (2006) Estrogen action in neuroprotection and brain inflammation. Ann N Y Acad Sci 1089:302-323
174. Pozzilli C, Falaschi P, Mainero C, Martocchia A, D'Urso R, Proietti A, Frontoni M, Bastianello S, Filippi M (1999) MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns. Neurology 53:622-624
175. Pozzilli C, Tomassini V, Marinelli F, Paolillo A, Gasperini C, Bastianello S (2003) 'gender gap' in multiple sclerosis: magnetic resonance imaging evidence. Eur J Neurol 10:95-97
176. Reder AT, Lowy MT (1993) Serum prolactin levels in active multiple sclerosis and during cyclosporin treatment. J Neurol Sci 117:192-196
177. Reder AT, Lowy MT, Meltzer HY, Antel JP (1987) Dexamethasone suppression test abnormalities in multiple sclerosis: Relation to ACTH therapy. Neurology 37:849-853
178. Reder AT, Thapar M, Jensen MA (1994) A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis: implications for treatment of inflammatory brain disease. Neurology 44:2289-2294
179. Riskind PN, Massacesi L, Doolittle TH, Hauser SL (1991) The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann Neurol 29:542-547
180. Rogister B, Ben-Hur T, Dubois-Dalcq M (1999) From neural stem cells to myelinating oligodendrocytes. Mol Cell Neurosci 14:287-300
181. Roitt IM (2006) Control mechanisms. In: Delves PJ, Martin SJ, Buron DR, Roitt IM (eds) Roitt's essential immunology. Blackwell Science, Oxford, pp 223-228
182. Roof RL, Duvdevani R, Heyburn JW, Stein DG (1996) Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Exp Neurol 138:246-251
183. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288:321-333
184. Rotondi M, Oliviero A, Profice P, Mone CM, Biondi B, Del Buono A, Mazziotti G, Sinisi AM, Bellastella A, Carella C (1998) Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis. J Endocrinol Invest 21:748-752
185. Sanchez-Ramon S, Navarro AJ, Aristimuno C, Rodriguez-Mahou M, Bellon JM, Fernandez-Cruz E, de Andres C (2005) Pregnancy-induced expansion of regulatory T lymphocytes may mediate protection to multiple sclerosis activity. Immunol Lett 96:195-201
186. Sanna V, Di Giacomo A, La Cava A, Lechler RI, Fontana S, Zappacosta S, Matarese G (2003) Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest 111:241-250
187. Santizo RA, Anderson S, Ye S, Koenig HM, Pelligrino DA (2000) Effects of estrogen on leukocyte adhesion after transient forebrain ischemia. Stroke 31:2231-2235
188. Schumacher M, Guennoun R, Robert F, Carelli C, Gago N, Ghoumari A, Gonzalez Deniselle MC, Gonzalez SL, Ibanez C, Labombarda F, Coirini H, Baulieu EE, De Nicola AF (2004) Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm IGF Res 14 [Suppl A]:S18-S33
189. Schumann EM, Kumpfel T, Then Bergh F, Trenkwalder C, Holsboer F, Auer DP (2002) Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume. Ann Neurol 51:763-767
190. Schwid SR, Goodman AD, Mattson DH (1997) Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b. Arch Neurol 54:1169-1190
191. Sena AH, Pedrosa RG, Cascais MJ, Andrade ML, Ferret-Sena VM, Morais MG (2006) Oral contraceptive use in patients with multiple sclerosis (abstract p04.120). Neurology 66:A229
192. Shah AK, Tselis A, Mason B (2000) Acute disseminated encephalomyelitis in a pregnant woman successfully treated with plasmapheresis. J Neurol Sci 174:147-151
193. Sicotte L, Giesser BS, Tandon V, Steiner B, Klutch R, Drain A, Shattuck DW, Hull L, Swerdloff R, Voskuhl RR (2006) A pilot study of testosterone treatment for men with relapsing remitting multiple sclerosis (abstract p01.070). Neurology Suppl 2:A30
194. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, Wu TC, Voskuhl RR (2002) Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 52:421-428
195. Smith DL, Du S, Wetmore KM, Arnold AP, Singh RR, Voskuhl RR (2006) The XX sex chromosome complement, as compared to the XY, confers greater susceptibility to experimental autoimmune encephalomyelitis and lupus. ACTRIMS Meeting 2006
196. Smith R, Studd JW (1992) A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J R Soc Med 85:612-613
197. Smith SR, Ravussin E (2006) Role of the adipocyte in metabolism and endocrine function. In: DeGroot LJ, Jameson JL (eds) Endocrinology. Elsevier Saunders, Philadelphia, pp 1045-1062
198. Soilu-Hanninen M, Airas L, Mononen I, Heikkila A, Viljanen M, Hanninen A (2005) 25-hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 11:266-271
199. Soldan SS, Alvarez Retuerto AI, Sicotte NL, Voskuhl RR (2003) Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol 171:6267-6274
200. Stefferl A, Linington C, Holsboer F, Reul JM (1999) Susceptibility and resistance to experimental allergic encephalomyelitis: Relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat. Endocrinology 140:4932-4938
201. Stefferl A, Storch MK, Linington C, Stadelmann C, Lassmann H, Pohl T, Holsboer F, Tilders FJ, Reul JM (2001) Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone. Endocrinology 142:3616-3624
202. Subramanian S, Matejuk A, Zamora A, Vandenbark AA, Offner H (2003) Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system. J Immunol 170:1548-1555
203. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291:228-238
204. Tellez N, Comabella M, Julia E, Rio J, Tintore M, Brieva L, Nos C, Montalban X (2006) Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone. Mult Scler 12:487-494
205. Then Bergh F, Grasser A, Trenkwalder C, Backmund H, Holsboer F, Rupprecht R (1999) Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis. J Neurol 246:292-298
206. Then Bergh F, Kumpfel T, Grasser A, Rupprecht R, Holsboer F, Trenkwalder C (2001) Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial. J Clin Endocrinol Metab 86:1610-1615
207. Thomas AJ, Nockels RP, Pan HQ, Shaffrey CI, Chopp M (1999) Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine 24:2134-2138
208. Thorogood M, Hannaford PC (1998) The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 105:1296-1299
209. Tomassini V, Onesti E, Mainero C, Giugni E, Paolillo A, Salvetti M, Nicoletti F, Pozzilli C (2005) Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry 76:272-275
210. Tritos NA, Kokkotou EG (2006) The physiology and potential clinical applications of ghrelin, a novel peptide hormone. Mayo Clin Proc 81:653-660
211. Trooster WJ, Teelken AW, Gerrits PO, Lijnema TH, Loof JG, Minderhoud JM, Nieuwenhuis P (1996) The effect of gonadectomy on the clinical course of chronic experimental allergic encephalomyelitis. Clin Neurol Neurosurg 98:222-226
212. Trooster WJ, Teelken AW, Kampinga J, Loof JG, Nieuwenhuis P, Minderhoud JM (1993) Suppression of acute experimental allergic encephalomyelitis by the synthetic sex hormone 17-alpha-ethinylestradiol: An immunological study in the Lewis rat. Int Arch Allergy Immunol 102:133-140
213. Van Etten E, Decallonne B, Verlinden L, Verstuyf A, Bouillon R, Mathieu C (2003) Analogs of 1alpha,25-dihydroxyvitamin d3 as pluripotent immunomodulators. J Cell Biochem 88:223-226
214. van Walderveen MA, Tas MW, Barkhof F, Polman CH, Frequin ST, Hommes OR, Valk J (1994) Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology 44:327-329
215. van Winsen LM, Muris DF, Polman CH, Dijkstra CD, van den Berg TK, Uitdehaag BM (2005) Sensitivity to glucocorticoids is decreased in relapsing remitting multiple sclerosis. J Clin Endocrinol Metab 90:734-740
216. VanAmerongen BM, Dijkstra CD, Lips P, Polman CH (2004) Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr 58:1095-1109
217. vanEtten E, Gysemans C, Branisteaunu DD et al (2007) Novel insights in the immune function of the vitamin d system: synergism with interferon beta. J Steroid Biochem Mol Biol 103:546-551
218. Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, Meda C, Krust A, Dupont S, Ciana P, Chambon P, Maggi A (2003) Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci U S A 100:9614-9619
219. Vegeto E, Bonincontro C, Pollio G, Sala A, Viappiani S, Nardi F, Brusadelli A, Viviani B, Ciana P, Maggi A (2001) Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 21:1809-1818
220. Vieth R, Chan PC, MacFarlane GD (2001) Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 73:288-294
221. Vieth R, Ladak Y, Walfish PG (2003) Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88:185-191
222. Villard-Mackintosh L, Vessey MP (1993) Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 47:161-168
223. Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P, Confavreux C, The Pregnancy In Multiple Sclerosis G (2004) Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127:1353-1360
224. Wartofsky L, Van Nostrand D, Burman KD (2006) Overt and 'subclinical' hypothyroidism in women. Obstet Gynecol Surv 61:535-542
225. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw WJ (2003) Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 289:2673-2684
226. Weatherby SJ, Mann CL, Davies MB, Fryer AA, Haq N, Strange RC, Hawkins CP (2000) A pilot study of the relationship between gadolinium-enhancing lesions, gender effect and polymorphisms of antioxidant enzymes in multiple sclerosis. J Neurol 247:467-470
227. Wei T, Lightman SL (1997) The neuroendocrine axis in patients with multiple sclerosis. Brain 120:1067-1076
228. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC (1989) The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 112:1419-1428
229. Weiss RE, Wu SY, Refetoff S (2006) Diagnostic tests of the thyroid IN: Endocrinology. Ed: LJ DeGroot and JL Jameson. Philadelphia: Elsevier Saunders 2006, 1899-1962
230. Wiersinga WM. Hypothyroidism and myxedema coma. In: DeGroot LJ, Jameson JL (eds) Endocrinology. Elsevier Saunders, Philadelphia, pp 2081-2099
231. Windaus A, Linsert O (1928) Vitamin D 1. Ann Chem 465:148
232. Wingerchuk DM, Lesaux J, Rice GP, Kremenchutzky M, Ebers GC (2005) A pilot study of oral calcitriol (1,25-dihydroxyvitamin d3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 76:1294-1296
233. Wingerchuk DM, Rodriguez M (2006) Premenstrual multiple sclerosis pseudoexacerbations: role of body temperature and prevention with aspirin. Arch Neurol 63:1005-1008
234. Younes-Rapozo V, Berendonk J, Savignon T, Manhaes AC, Barradas PC (2006) Thyroid hormone deficiency changes the distribution of oligodendrocyte/myelin markers during oligodendroglial differentiation in vitro. Int J Dev Neurosci 24:445-453
235. Zivadinov R, Rudick RA, De Masi R, Nasuelli D, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M (2001) Effects of iv methylprednisolone on brain atrophy in relapsingremitting MS. Neurology 57:1239-1247
236. Zorgdrager A, De Keyser J (1997) Menstrually related worsening of symptoms in multiple sclerosis. J Neurol Sci 149:95-97
237. Zorgdrager A, De Keyser J (2002) The premenstrual period and exacerbations in multiple sclerosis. Eur Neurol 48:204-206